38 results
F-4
EX-10.11
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
Listing Authority’s Listing, Prospectus, and Disclosure and Transparency Rules.
You shall have particular regard to the general duties of directors … and Transparency Rules of the UK Listing Authority and section 52 of the Criminal Justice Act 1993 on insider dealing. You should avoid making any
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
30 Jun 20
Result of Annual General Meeting
4:07pm
to notify their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority
F-4
EX-10.13
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
Rules for Companies, the UK Listing Authority’s Listing, Prospectus, and Disclosure and Transparency Rules.
You shall have particular regard … as to the disclosure of inside information, in particular to the Disclosure and Transparency Rules of the UK Listing Authority and section 52 of the Criminal
F-4
EX-10.10
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
Rules for Companies, the UK Listing Authority’s Listing, Prospectus, and Disclosure and Transparency Rules.
You shall have particular regard … as to the disclosure of inside information, in particular to the Disclosure and Transparency Rules of the UK Listing Authority and section 52 of the Criminal
F-4
EX-10.12
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
Rules for Companies, the UK Listing Authority’s Listing, Prospectus, and Disclosure and Transparency Rules.
You shall have particular regard … as to the disclosure of inside information, in particular to the Disclosure and Transparency Rules of the UK Listing Authority and section 52
F-4
EX-10.8
pxk5w37dxcbyk1v
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.9
6euxe6 2v
25 Jan 19
Registration of securities (foreign)
12:00am
6-K
fin84ywxkrq 35kk3p70
21 Jun 19
Current report (foreign)
11:10am
20-F
EX-4.19
tp8g rrktu27hs9ojs
29 Apr 19
Annual report (foreign)
4:59pm
6-K
EX-99.1
ci6tvrfwxinzgizuv
19 Feb 20
Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor
9:32am
6-K
0zs9b2w
24 Apr 19
Current report (foreign)
2:24pm
6-K
EX-99.1
zpti58d
10 Feb 20
Current report (foreign)
7:20am
425
p0h ipxd6da40
15 Mar 19
Business combination disclosure
8:34am
6-K
1ss57800m 9tanykihz
23 Apr 19
Current report (foreign)
4:14pm
6-K
EX-99.1
ivppj0a7if4
12 Nov 20
Current report (foreign)
6:15am
425
8b5slsb8sw0ud
6 Dec 18
Business combination disclosure
2:27pm
20-F
EX-4.13.1
krlthmzo
29 Apr 19
Annual report (foreign)
4:59pm
10-K
tq9um 6z7
27 Mar 24
Annual report
5:20pm
20-F
5wz0l eqj7u37b
29 Apr 19
Annual report (foreign)
4:59pm